Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

PALO ALTO, Calif., May 15, 2024 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended March 31, 2024. “We continue to make excellent operational progress with our three clinical programs of tarcocimab, KSI-501…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks